Catch up on the top radiology content of the past week.
|Articles|March 15, 1995
Imatron 1994 revenues rise by 34%
Imatron, a manufacturer of ultra-high-speed CT systems, reported that sales jumped by 34% and the companyreturned to profitability in 1994 (ending Dec. 31). Revenues last year totaled a record $33.5 million, comparedto $25.1 million in 1993. Profits
Advertisement
Imatron, a manufacturer of ultra-high-speed CT systems, reported that sales jumped by 34% and the companyreturned to profitability in 1994 (ending Dec. 31).
Revenues last year totaled a record $33.5 million, comparedto $25.1 million in 1993. Profits were $2.3 million.
The financial good news is a continuation of positive trendsthat emerged in the second half of 1993, according to S. LewisMeyer, chief executive officer.
"The company moves into 1995 with a strong backlog anda high degree of optimism in our ability to continue growing,"he said.
Imatron is gearing up sales and marketing efforts in the PacificRim, Latin America and the Middle East. The launch of HeartScan,a subsidiary that will manage artery disease risk assessment centersequipped with Imatron high-speed CT scanners, is scheduled forthe first quarter of 1995, Meyer said.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
Emerging Research Insights and New Advances in Neuroradiology
3
MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?
4
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
5